Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07585669Not ApplicableRecruiting

Effects of Omega-3 Fatty Acids on Inflammation and Gut Microbiota in Celiac Disease

Role: collaborator

NCT07437846Not ApplicableRecruiting

Impact of PEEP on Respiratory Effort During Assisted Ventilation

Role: collaborator

NCT07398820Completed

IMPACT OF SEDENTARY BEHAVIOR IN THE HOMEOSTASIS OF THE DIGESTIVE ECOSYSTEM

Role: lead

NCT06758024Not ApplicableRecruiting

PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

Role: collaborator

All 4 trials loaded